Company Search:
Advanced Search
Sponsored Links
Aratana Therapeutics Inc Company Snapshot
Aratana Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aratana Therapeutics Inc with three other companies in this sector in the United States: Portola Pharmaceuticals Inc (2016 sales of $35.50 million ), Achaogen Inc ($41.77 million of which 100% was Biopharmaceutical), and Jounce Therapeutics Inc ($37.20 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aratana Therapeutics Inc
  Stock Performance Chart for Aratana Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 5.24
(Figures in U.S. Dollars)
1 Week -23.2%   13 Weeks -17.4%  
4 Weeks -32.3%   52 Weeks 16.2%  
Aratana Therapeutics Inc Key Data:
  Ticker: PETX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 38,551,000
(Year Ending Jan 2017).
Employees: 85
  Currency: U.S. Dollars Market Cap: 195,781,355
  Fiscal Yr Ends: December Shares Outstanding: 37,362,854
  Share Type: Common Closely Held Shares: 1,722,295
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.